{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:08:41Z","timestamp":1750133321073,"version":"3.41.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study evaluated the potential of Wharton's jelly mesenchymal stem cells with high tolerogenic properties in reducing immunosuppressive dosage and related adverse effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A 4- to 6-week-old, 30\u201340 g weight, male inbred CD57BL\/6 mice were used as skin allograft donors, whereas Balb\/c mice with similar characteristics were used as recipients. Wharton's jelly stem cells were obtained from a commercial kit sourced from human umbilical cord. Skin allografts were performed from CD57Bl6 to Balb\/c mice (day 0). Group 1 (control) received no treatment. Group 2 received 15 mg\/kg cyclosporin A on days 0 to 30. Group 3 received 5.7 \u00d7 10<jats:sup>6<\/jats:sup> and 10.3 \u00d7 10<jats:sup>6<\/jats:sup> cell\/kg Wharton's jelly stem cells on days 0 and 3, respectively. Groups 4, 5, and 6 received a combination of 15, 10, and 5 mg\/kg per day cyclosporine A (days 0 to 30) with the same stem cell dose with group 3, respectively. Graft rejection was evaluated with digital photography and thermal imaging, histopathology (Banff grading, epithelialization scores, dermoepidermal dissociation), immunochemistry (Ki-67 and Bcl-2), and biochemical methods (interleukin 10, interleukin 2, interferon \u03b3, tumor necrosis factor \u03b1) (day 10). Cumulative adverse effects of cyclosporin A occurring in the groups were revealed by histopathological evaluation of kidney and liver (a modified semiquantitative method of infiltration of inflammatory cells around the portal area and lobular region in liver; modification of the Banff rating of proximal tubules and hypertrophia of juxtaglomerular apparatus cells in kidney) (day 30).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There was no rejection in groups 2, 4, and 5 until the end of study. These were statistically different versus groups 1 (day 10 \u00b1 0.71), 3 (day 11 \u00b1 0.82), and 6 (day 11 \u00b1 0.58) (all <jats:italic toggle=\"yes\">P<\/jats:italic>'s &lt; 0.05). Groups 4 and 5 have exhibited statistically similar findings in histopathological (4 epithelization score: 3.7 \u00b1 1.3; 5 epithelization score: 3.5 \u00b1 0.5; 4 Banff grading score: 0.8 \u00b1 0.6; 5 Banff grading score: 1.0 \u00b1 0.5; both <jats:italic toggle=\"yes\">P<\/jats:italic>'s = 1.00), immunohistochemical (4 Bcl-2 score: 3.5 \u00b1 0.5, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.618; 5 Bcl-2 score: 3.4 \u00b1 0.5, <jats:italic toggle=\"yes\">P<\/jats:italic> = 1.00; 4 Ki-67 score: 3.7 \u00b1 0.4, <jats:italic toggle=\"yes\">P<\/jats:italic> = 1.00; 5 Ki-67 score: 3.5 \u00b1 0.5, both <jats:italic toggle=\"yes\">P<\/jats:italic>'s = 1.00), and levels of cytokines (both <jats:italic toggle=\"yes\">P<\/jats:italic>'s = 1.00) versus group 2. Adverse effects on kidneys and liver were lowest and statistically similar in groups 3, 5, and 6 (all <jats:italic toggle=\"yes\">P<\/jats:italic>'s = 00) versus group 1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Wharton's jelly mesenchymal stem cells alter bioavailability of cyclosporine, albeit at much lower doses and with fewer systemic adverse effects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000003314","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T15:00:59Z","timestamp":1669215659000},"page":"684-693","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Stem Cells Derived From the Mesenchyme of the Umbilical Cord in Reducing Immunosuppressive Drug Doses Used in Allogenic Transplantations"],"prefix":"10.1097","volume":"89","author":[{"given":"Seyda","family":"Guray Evin","sequence":"first","affiliation":[{"name":"Department of Plastic Reconstructive and Aesthetic Surgery, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Sutcu","sequence":"additional","affiliation":[{"name":"Plastic Reconstructive and Aesthetic Surgery, Selcuk University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahsin Murad","family":"Aktan","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Necmettin Erbakan University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selcuk","family":"Duman","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Necmettin Erbakan University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Harmankaya","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"Abusoglu","sequence":"additional","affiliation":[{"name":"Medical Biochemistry, Selcuk University Faculty of Medicine, Konya, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250616","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","article-title":"Long-term survival in renal transplant recipients with graft function","volume":"57","year":"2000","journal-title":"Kidney Int"},{"key":"bib2-20250616","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/dtb.1994.32966","article-title":"Immunosuppressive drugs and their complications","volume":"32","year":"1994","journal-title":"Drug Ther Bull"},{"key":"bib3-20250616","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2106\/00004623-200210000-00020","article-title":"The spectrum of complications of immunosuppression: is the time right for hand transplantation?","volume":"84","year":"2002","journal-title":"J Bone Joint Surg Am"},{"key":"bib4-20250616","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1098-2752(2000)20:8<360::AID-MICR4>3.0.CO;2-E","article-title":"Hand transplantation: comparisons and observations of the first four clinical cases","volume":"20","year":"2000","journal-title":"Microsurgery"},{"key":"bib5-20250616","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/S0041-1345(98)00800-8","article-title":"The case for local immunosuppression in composite tissue allotransplantation","volume":"30","year":"1998","journal-title":"Transplant Proc"},{"key":"bib6-20250616","first-page":"473","article-title":"Characterization of a cyclosporine-containing liposome","volume":"23","year":"1991","journal-title":"Transplant Proc"},{"key":"bib7-20250616","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/81395","article-title":"Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep","volume":"6","year":"2000","journal-title":"Nat Med"},{"key":"bib8-20250616","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trim.2008.08.004","article-title":"Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate","volume":"20","year":"2008","journal-title":"Transpl Immunol"},{"key":"bib9-20250616","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"bib10-20250616","first-page":"3548917","article-title":"The immunomodulatory potential of Wharton's jelly mesenchymal stem\/stromal cells","volume":"2019","year":"2019","journal-title":"Stem Cells Int"},{"key":"bib11-20250616","article-title":"Wharton's jelly mesenchymal stem cells as off-the-shelf cellular therapeutics: a closer look into their regenerative and immunomodulatory properties","volume":"4","year":"2011","journal-title":"Open Tissue Eng Regen Med J"},{"key":"bib12-20250616","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2152\/jmi.54.267","article-title":"Analysis of skin graft survival using green fluorescent protein transgenic mice","volume":"54","year":"2007","journal-title":"J Med Invest"},{"key":"bib13-20250616","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1084\/jem.172.5.1483","article-title":"Migration and maturation of Langerhans cells in skin transplants and explants","volume":"172","year":"1990","journal-title":"J Exp Med"},{"key":"bib14-20250616","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/wrr.12445","article-title":"A new method for skin grafting in murine model","volume":"24","year":"2016","journal-title":"Wound Repair Regen"},{"key":"bib15-20250616","article-title":"Thermal imaging in skin trauma evaluation: observations by CAT S60 mobile phone","volume":"10","year":"2018","journal-title":"Finnish J eHealth eWelfare"},{"key":"bib16-20250616","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.burns.2017.04.006","article-title":"The FLIR ONE thermal imager for the assessment of burn wounds: reliability and validity study","volume":"43","year":"2017","journal-title":"Burns"},{"key":"bib17-20250616","first-page":"689071","article-title":"Immunology of vascularized composite allografts","volume":"2013","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"bib18-20250616","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clindermatol.2004.07.022","article-title":"Immunology of skin transplantation","volume":"23","year":"2005","journal-title":"Clin Dermatol"},{"key":"bib20-20250616","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1600-6143.2008.02243.x","article-title":"The Banff 2007 working classification of skin-containing composite tissue allograft pathology","volume":"8","year":"2008","journal-title":"Am J Transplant"},{"key":"bib21-20250616","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1600-6143.2004.00518.x","article-title":"Steroid- and ATG-resistant rejection after double forearm transplantation responds to Campath-1H","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"bib22-20250616","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/00007890-199709270-00023","article-title":"Prolonged survival of rat skin allograft by treatment with FK506 ointment","volume":"64","year":"1997","journal-title":"Transplantation"},{"key":"bib23-20250616","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12072-017-9793-2","article-title":"CSH guidelines for the diagnosis and treatment of drug-induced liver injury","volume":"11","year":"2017","journal-title":"Hepatol Int"},{"key":"bib24-20250616","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","year":"1999","journal-title":"Kidney Int"},{"key":"bib25-20250616","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/ndt\/6.5.363","article-title":"The effect of conversion from cyclosporin to azathioprine on renin-containing cells in renal allograft biopsies","volume":"6","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"bib26-20250616","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ki.1995.438","article-title":"Cyclosporine enhances the expression of TGF-beta in the juxtaglomerular cells of the rat kidney","volume":"48","year":"1995","journal-title":"Kidney Int"},{"key":"bib27-20250616","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jss.2008.09.027","article-title":"Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation","volume":"160","year":"2010","journal-title":"J Surg Res"},{"key":"bib28-20250616","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/PRS.0b013e318200a92c","article-title":"Prolongation of composite tissue allotransplant survival by treatment with bone marrow mesenchymal stem cells is correlated with T-cell regulation in a swine hind-limb model","volume":"127","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"bib29-20250616","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.3390\/molecules16053969","article-title":"Consecutive low doses of cyclosporine a induce pro-inflammatory cytokines and accelerate allograft skin rejection","volume":"16","year":"2011","journal-title":"Molecules"},{"key":"bib30-20250616","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/PRS.0b013e3182547de1","article-title":"Vascularized bone marrow allotransplantation and low-dose cyclosporine prolong the survival of adipose tissue allografts","volume":"130","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"bib31-20250616","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1258\/0023677053739792","article-title":"Quantitative assessment of mouse skin transplant rejection using digital photography","volume":"39","year":"2005","journal-title":"Lab Anim"},{"key":"bib32-20250616","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0306-3623(94)00113-2","article-title":"The pharmacology of immunosuppressant drugs in skin transplant rejection in mice and other rodents","volume":"26","year":"1995","journal-title":"Gen Pharmacol Vasc S"},{"key":"bib33-20250616","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/stem.230","article-title":"Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors","volume":"27","year":"2009","journal-title":"Stem Cells"},{"key":"bib34-20250616","first-page":"174","article-title":"Intracranial transplantation of human adipose\u2013derived stem cells promotes the expression of neurotrophic factors and nerve repair in rats of cerebral ischemia-reperfusion injury","volume":"7","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"bib35-20250616","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1089\/scd.2011.0447","article-title":"Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"21","year":"2012","journal-title":"Stem Cells Dev"},{"issue":"suppl 1","key":"bib36-20250616","first-page":"S21","article-title":"Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche","volume":"4","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"bib37-20250616","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.1073\/pnas.0504388102","article-title":"Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction","volume":"102","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib38-20250616","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00403-007-0827-9","article-title":"Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model","volume":"300","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"bib39-20250616","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cellimm.2009.06.010","article-title":"Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues","volume":"259","year":"2009","journal-title":"Cell Immunol"},{"key":"bib40-20250616","doi-asserted-by":"crossref","first-page":"e9016","DOI":"10.1371\/journal.pone.0009016","article-title":"Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially","volume":"5","year":"2010","journal-title":"PLoS One"},{"key":"bib41-20250616","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ebiom.2018.01.002","article-title":"Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-\u03b3","volume":"28","year":"2018","journal-title":"EBioMedicine"},{"key":"bib42-20250616","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.tp.0000209919.90630.7b","article-title":"Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model","volume":"81","year":"2006","journal-title":"Transplantation"},{"key":"bib43-20250616","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.trim.2011.06.002","article-title":"Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model","volume":"25","year":"2011","journal-title":"Transpl Immunol"},{"key":"bib44-20250616","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","year":"2005","journal-title":"Blood"},{"key":"bib45-20250616","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbmt.2005.08.039","article-title":"Human mesenchymal stem cells and cyclosporin A exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes","volume":"11","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"bib46-20250616","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0300-9475.2004.01483.x","article-title":"Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes","volume":"60","year":"2004","journal-title":"Scand J Immunol"},{"key":"bib47-20250616","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.taap.2011.02.015","article-title":"Identification of novel indicators of cyclosporine a nephrotoxicity in a CD-1 mouse model","volume":"252","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"bib48-20250616","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01972366","article-title":"Cyclosporine: immunology, toxicity and pharmacology in experimental animals","volume":"15","year":"1984","journal-title":"Agents Actions"},{"key":"bib49-20250616","first-page":"117","article-title":"Tissue distribution and toxicity of cyclosporin a in the mouse","volume":"16","year":"1984","journal-title":"Pathology"},{"key":"bib50-20250616","first-page":"437","article-title":"Pathological changes in rats receiving cyclosporin a at immunotherapeutic dosage for 7 weeks","volume":"64","year":"1983","journal-title":"Br J Exp Pathol"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000003314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T23:08:22Z","timestamp":1750115302000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000003314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000003314","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"type":"electronic","value":"1536-3708"},{"type":"print","value":"0148-7043"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}